Study reveals geographic and sociodemographic factors driving epilepsy incidence among older U.S. adults, highlighting regional disparities and associated risk factors.

The 2024 cancer report highlights declines in US cancer mortality through 2022, with 2020 pandemic-related diagnosis drops not persisting into 2021. Key insights for oncology insurers and providers.